Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2010
03/02/2010US7670844 Supported molecular biofluid viscosity sensors for in vitro and in vivo use
03/02/2010US7670843 Polymeric film sensor for polycyclic aromatic hydrocarbons
03/02/2010US7670842 Method for discriminating organic agricultural products from conventional agricultural products by using nitrogen isotope index
03/02/2010US7670841 Dehydrating gel on which target peptide that has been separated by electrophoresis, immersing in mixture of alkanoic acid anhydride and perfluoroalkanoic acid in dipolar aprotic solvent to re-swell gel carrier; mass spectrometry
03/02/2010US7670833 Employing micro-array format; for use on human tissues
03/02/2010US7670832 System for fluorescence monitoring
03/02/2010US7670831 Detects various target biomaterials that bind or react with the bioreceptors by precisely measuring directly or by electrochemical signals at large amounts in one step
03/02/2010US7670816 UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1
03/02/2010US7670805 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments
03/02/2010US7670801 Using immunoglobulins to isolate heterologous polypeptide fusion comprising viral coat sequences in adenoviral protein expression systems of plants, animals and bacteria
03/02/2010US7670799 dissolving the TCPP in an aqueous alcoholic solution; efficient solubilizing, improved staining ; for detect dysplastic, pre-cancerous, and cancerous cells from various tissue samples both in vitro and in situ
03/02/2010US7670798 Automated method and reagent therefor assaying body fluid samples such as cerebrospinal fluid (CSF)
03/02/2010US7670797 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined
03/02/2010US7670793 Enumeration of CD4+ lymphocytes
03/02/2010US7670792 Biomarkers for early detection of ovarian cancer
03/02/2010US7670791 regulating an alpha 1G T-type calcium channel in the central nervous system and alpha 1H and alpha 1I T-type calcium channels in the peripheral nervous system; analegesic
03/02/2010US7670790 Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders
03/02/2010US7670789 Determining MRP-8/14 protein or haptoglobin presence in fluid or tissue sample in patient without interfering condition such as cancer, meningitis, pneumonia, tuberculosis, septicemia, rheumatic arthritis, inflammatory bowel disease, AIDS; or periodontal, skin or gastrointestinal disorders; immunoassay
03/02/2010US7670788 Botulin toxin-B amino acid sequences comprising reduced immunogenicity for use as components of therapeutic and cosmetic treatments
03/02/2010US7670787 Protein forming complex with c-Fos protein, nucleic acid encoding the same and method of using the same
03/02/2010US7670786 Membrane-based assay devices
03/02/2010US7670785 Drug screening for a compound that modulates the NF kappa B activity of a guanylate binding protein associated with rheumatoid arthritis
03/02/2010US7670784 β-Benzyloxyaspartic acid derivatives having two substituents on their benzene rings
03/02/2010US7670783 Screening for neurotoxic amino acid associated with neurological disorders
03/02/2010US7670782 Screening of compounds for CAT1 transporter activity
03/02/2010US7670781 Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal
03/02/2010US7670775 Using phospholipase expression profile as diagnostic/predicitve tool in classifying tumor malignancy
03/02/2010US7670770 comprising surface having a plurality of channels having a trench width of less than about 150 nanometers and depth of less than 200 nanometers
03/02/2010US7670769 IL1RL-1 as a cardiovascular disease marker and therapeutic target
03/02/2010US7670766 Early detection of flaviviruses using the NS1 glycoprotein
03/02/2010US7670765 Method of forming monolayers of phage-derived products and used thereof
03/02/2010US7670764 Methods of diagnosing tissue fibrosis
03/02/2010US7670763 determining sperm quality, and different storage media's effect thereon; male fertility
03/02/2010US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders
03/02/2010US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab
03/02/2010US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
03/02/2010US7670562 Dispensing container and storage container for analytical disposables
03/02/2010US7670559 Reduction of static fluid flow within a sample channel; obtain microfluidic apparatus, insert and allow fluid to flow through channels, screen fluid for preferential particles
03/02/2010US7670556 Generation of solid supports; obtain thin film with grooves coated with substrate, expose to biopolymers, allow binding, remove thin film, recover microarray
03/02/2010US7670470 Biosensor membranes composed of polymers containing heterocyclic nitrogens
03/02/2010US7669460 Small-scale shock reactivity and internal blast test
03/02/2010CA2390659C Ny-eso-1 peptide derivatives, and uses thereof
03/02/2010CA2190359C Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
02/2010
02/28/2010CA2676826A1 Formation gas pore pressure evaluation on drilling cuttings samples
02/28/2010CA2675800A1 Methods and apparatus for decreasing a density of a downhole fluid
02/28/2010CA2639395A1 Mini core in drilling samples for high resolution formation evaluation on drilling cuttings samples
02/25/2010WO2010022400A2 Rapid identification of proteins and their corresponding source organisms by gas phase fragmentation and identification of protein biomarkers
02/25/2010WO2010022398A1 Diagnosis and treatment of neuro-inflammatory disorders
02/25/2010WO2010022391A2 Integrated, automated system for the study of cell and tissue function
02/25/2010WO2010022332A1 Method for chromogenic detection of two or more target molecules in a single sample
02/25/2010WO2010022289A2 Methods for removal of specific seed tissue or structure for seed analysis
02/25/2010WO2010022288A1 High throughput system for cfu assay by the use of high resolution digital imaging, differential staining and automated laboratory system
02/25/2010WO2010022286A2 Apparatus for removal of specific seed tissue or structure for seed analysis
02/25/2010WO2010022281A1 Methods for using human neutrophil elastase as an indicator of active wound infection
02/25/2010WO2010022279A1 Antibodies and related molecules that bind to 58p1d12 proteins
02/25/2010WO2010022268A2 Markers for assessing the susceptibility of cancer to igf-1r treatment
02/25/2010WO2010022227A1 Methods for monitoring il-10 therapy
02/25/2010WO2010022222A1 Method for evaluating high temperature wear life
02/25/2010WO2010022210A2 Diagnosis and monitoring of renal failure using peptide biomarkers
02/25/2010WO2010022202A1 Kinetic biologic activity assays and kinetic von willebrand assay
02/25/2010WO2010022145A2 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function
02/25/2010WO2010022143A2 Assessing and treating breast cancer patients
02/25/2010WO2010022057A1 Method and system for biofouling control of shipboard components
02/25/2010WO2010021989A1 Multiplex assay for rheumatoid arthritis
02/25/2010WO2010021978A2 Il-8 biomarker
02/25/2010WO2010021914A2 Calibration surface method for determination of analyte ratios
02/25/2010WO2010021870A1 A method for the analysis of o-linked oligosaccharides
02/25/2010WO2010021859A1 Compositions and methods for diagnosis and treatment of pancreatic ductal cancer
02/25/2010WO2010021849A2 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae
02/25/2010WO2010021846A2 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae
02/25/2010WO2010021822A2 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
02/25/2010WO2010021639A1 Attomolar protein detection in complex damle matrices with semi-homogeneous fluidic force discrimination assays
02/25/2010WO2010021627A1 Cell analysis apparatus and methods
02/25/2010WO2010021586A1 A method of characterizing antibodies
02/25/2010WO2010021521A2 Method for increasing sensitivity using linker and spacer in carbon nanotube-based biosensor
02/25/2010WO2010021509A2 Quantification method of biochemical substances using ion scattering spectroscopy and specific-binding efficiency quantification method of biochemical substances using ion scattering spectroscopy
02/25/2010WO2010021423A1 Method for diagnosis of post-operative recurrence in patients with hepatocellular carcinoma
02/25/2010WO2010021399A1 Cystatin c adsorption inhibitor
02/25/2010WO2010021396A1 Method for quantification or detection of dna
02/25/2010WO2010021394A1 Method for quantification or detection of dna
02/25/2010WO2010021372A1 Test apparatus for membrane assay equipped with reference display section
02/25/2010WO2010021283A1 Tool for determining degradation of lubricating oil and method for determining degradation of lubricating oil
02/25/2010WO2010021092A1 Method for testing on risk of metabolic syndrome or cardiovascular disease, and kit for risk test
02/25/2010WO2010021088A1 Liquid specimen analysis device
02/25/2010WO2010020912A1 Apparatus and method for molecule detection using nanopores
02/25/2010WO2010020893A1 Methods for screening and arraying microrganisms such as viruses using subtractive contact printing background
02/25/2010WO2010020812A1 Identification of sample components
02/25/2010WO2010020673A2 Transcutaneous organ function measurement
02/25/2010WO2010020647A2 New method for identifying compounds useful for treating and/or preventing disease-associated bone loss
02/25/2010WO2010020618A1 Susceptibility to hsp90-inhibitors
02/25/2010WO2010020590A1 Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
02/25/2010WO2010020574A1 Microfluidic system
02/25/2010WO2010020435A1 Universal flash system and apparatus for petroleum reservoir fluids study
02/25/2010WO2010020236A1 Method for determining the gas quality of syngas
02/25/2010WO2010020177A1 Calculation method for fiber heat moisture transmission
02/25/2010WO2010020058A1 A method of diagnosing a respiratory disease
02/25/2010WO2010020037A1 The identification of disease-induced biomarkers in the urine of bse infected cattle
02/25/2010WO2010019997A1 Monoclonal antibody stro-4
02/25/2010WO2010004436A3 Enhanced immunoassay sensor
02/25/2010WO2010001074A3 Novel detection probe
1 ... 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 ... 3937